Decision Resources, Inc., one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds there is significant commercial opportunity for pharmaceutical companies interested in entering the drug market to treat adult Attention-Deficit/Hyperactivity Disorder (ADHD). Recent studies have shown that the prevalence of adult ADHD in the United States exceeds 4%.

The new Spectrum report entitled Opportunities and Challenges in the Adult Attention-Deficit/Hyperactivity Disorder Market, also finds that the growth is being driven primarily by an increase in the diagnosed, drug-treated adult population.

"Growth of the adult population has picked up, especially since the approval of Eli Lilly's Strattera for ADHD treatment in 2003 and Shire's Adderall XR in 2004 for the treatment of adult ADHD. Before 2003, no drugs were approved for treatment of ADHD in adults," said Anathea Waitekus, analyst at Decision Resources, Inc. "With this recent growth, the drug-treated adult ADHD population now rivals the adult drug-treated populations of other psychiatric diseases, such as bipolar disorder and social anxiety disorder."

About Spectrum from Decision Resources

Spectrum is an executive advisory service that identifies and analyzes key business and technology drivers of the pharmaceutical and biotechnology markets. Available only through Decision Resources, Spectrum is a mix of publications and telephone inquiry access to analysts that provides an "over the horizon" perspective on complex health care issues.

About Decision Resources

Decision Resources, Inc., (http://www.decisionresources.com/) is a world leader in market research publications, advisory services, and consulting designed to help clients shape strategy, allocate resources, and master their chosen markets.

All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.

  For more information, contact:    Elizabeth Marshall    Decision Resources, Inc.    781-296-2563    emarshall@dresources.com 

SOURCE: Decision Resources, Inc.

CONTACT: Elizabeth Marshall of Decision Resources, Inc.,
+1-781-296-2563, emarshall@dresources.com

Despite Serious Medicaid Problems, Missouri Legislature Holds Off on Implementing Recommended Reforms, According to HealthLeaders-InterStudy

View Now